"Microphthalmos" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Congenital or developmental anomaly in which the eyeballs are abnormally small.
| Descriptor ID |
D008850
|
| MeSH Number(s) |
C11.250.566 C16.131.384.666
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Microphthalmos".
Below are MeSH descriptors whose meaning is more specific than "Microphthalmos".
This graph shows the total number of publications written about "Microphthalmos" by people in this website by year, and whether "Microphthalmos" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Microphthalmos" by people in Profiles.
-
Salsi V, Magdinier F, Tupler R. Does DNA Methylation Matter in FSHD? Genes (Basel). 2020 02 28; 11(3).
-
Irazoqui JE. Key Roles of MiT Transcription Factors in Innate Immunity and Inflammation. Trends Immunol. 2020 02; 41(2):157-171.
-
Mul K, Lemmers RJLF, Kriek M, van der Vliet PJ, van den Boogaard ML, Badrising UA, Graham JM, Lin AE, Brand H, Moore SA, Johnson K, Evangelista T, T?pf A, Straub V, Kapetanovic Garc?a S, Sacconi S, Tawil R, Tapscott SJ, Voermans NC, van Engelen BGM, Horlings CGC, Shaw ND, van der Maarel SM. FSHD type 2 and Bosma arhinia microphthalmia syndrome: Two faces of the same mutation. Neurology. 2018 08 07; 91(6):e562-e570.
-
Awadalla MS, Burdon KP, Souzeau E, Landers J, Hewitt AW, Sharma S, Craig JE. Mutation in TMEM98 in a large white kindred with autosomal dominant nanophthalmos linked to 17p12-q12. JAMA Ophthalmol. 2014 Aug; 132(8):970-7.
-
Patil SB, Hurd TW, Ghosh AK, Murga-Zamalloa CA, Khanna H. Functional analysis of retinitis pigmentosa 2 (RP2) protein reveals variable pathogenic potential of disease-associated missense variants. PLoS One. 2011; 6(6):e21379.